Physician

Minesh D Patel, MD

According to 2025 Medicare claims, Minesh Patel, MD (NPI: 1699094300) practices hematology/oncology in the Atlanta-Sandy Springs-Roswell, GA market, with the plurality of this provider's patient population coming from Coweta, GA. This provider's primary affiliated billing organization is PIEDMONT CANCER INSTITUTE PC (NPI: 1336180637; TIN: 581761689) and primary practice location at 30265-8303.

Patel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 675 traditional Medicare patients, billed 309,686 HCPCS/CPT codes, and received $6,093,325 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 5,126 prescription claims across 622 beneficiaries totaling $10,489,228 in drug costs, led by Revlimid (Lenalidomide). DME data shows 48 claims. Open Payments data shows 25 records totaling $566. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $331,289 to $6,093,325. Similarly, Part D prescription costs have moved sharply higher in recent years, from $97,345 to $10,489,228. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	281	33,826	$331,289
2017	567	184,147	$1,329,498
2018	576	200,922	$1,729,522
2019	636	250,981	$2,334,120
2020	620	204,314	$2,809,218
2021	660	314,306	$4,578,811
2022	681	272,685	$4,950,977
2023	652	283,464	$4,778,311
2024	675	309,686	$6,093,325

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	45	108	$97,345
2016	101	232	$170,937
2017	266	1,710	$1,633,069
2018	309	2,232	$2,766,973
2019	374	2,784	$3,607,004
2020	388	3,045	$3,714,499
2021	450	3,739	$6,579,439
2022	535	4,062	$7,070,162
2023	575	4,493	$8,008,377
2024	622	5,126	$10,489,228

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	25	$6,011
2018	N/R	11	$4,510
2019	N/R	N/R	N/R
2020	N/R	11	$1,249
2021	N/R	245	$111,768
2022	N/R	69	$5,141
2023	N/R	13	$1,954
2024	N/R	48	$9,612

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	136	301	$83
96413	Administration of chemotherapy into vein, 1 hour or less	116	725	$83
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	413	818	$57
96372	Injection of drug or substance under skin or into muscle	127	683	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	527	1,460	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	191	5,033	$2,716,397
Venclexta	Venetoclax	69	2,042	$837,637
Brukinsa	Zanubrutinib	36	1,080	$538,728
Xtandi	Enzalutamide	36	1,080	$491,334
Imbruvica	Ibrutinib	31	868	$485,898

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
B4185	Parenteral nutrition solution, not otherwise specified, 10 grams lipids	N	N/R	16	$5,763
B4224	Parenteral nutrition administration kit, per day	N	N/R	16	$2,916
B4220	Parenteral nutrition supply kit; premix, per day	N	N/R	16	$933

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	25	$566	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Minesh D. Patel, MD?

Tedicare shows public-source Medicare data for Minesh D. Patel, MD (NPI 1699094300), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Minesh D. Patel, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Minesh D. Patel, MD?

Minesh D. Patel, MD is linked to PIEDMONT CANCER INSTITUTE PC (billing NPI 1336180637) in the available physician profile data.

Does Minesh D. Patel, MD have Open Payments data?

Minesh D. Patel, MD has 25 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.